DEKA Research & Development Corp.
↗Manchester, NH, USA
DEKA Research & Development is a prominent, privately-held engineering and technology development firm founded by inventor Dean Kamen. Based in Manchester, New Hampshire, the company specializes in creating innovative medical devices, advanced robotics, and sustainable technology solutions, often licensing its intellectual property to major industry partners.
The company is renowned for its diverse portfolio, which includes portable dialysis systems, automated insulin delivery systems (such as the FDA-cleared twiist® pump), mobility devices like the iBOT® wheelchair, and water purification technologies. DEKA operates as an R&D powerhouse, leveraging a large team of engineers and scientists to translate complex concepts into functional, life-changing products.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$40M-$50M
Founded:1982
Ownership:private
Status:operating
FUNDING
Total Raised:$0
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Medical Device focus)
Modalities:Medical Devices, Infusion Systems, Robotics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Baxter Healthcare (Dialysis), Johnson & Johnson (iBOT), Breakthrough T1D (Diabetes research)
COMPETITION
Position:Leader
Competitors:IDEO, TIAX, Frog Design
LEADERSHIP
Key Executives:
Dean Kamen - Founder and President
Scientific Founders:Dean Kamen
LINKS
Website:dekaresearch.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of DEKA Research & Development Corp. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with DEKA Research & Development Corp.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.